A52.1 Symptomatic neurosyphilis

Name of the Condition

• Symptomatic neurosyphilis

Summary

Symptomatic neurosyphilis is a late-stage manifestation of syphilis infection that affects the nervous system, resulting in clinical symptoms. It occurs when the bacterium Treponema pallidum invades the central nervous system, leading to neurological dysfunction. This condition can involve the brain, spinal cord, or peripheral nerves and may present with a range of neurological signs and symptoms.

Causes

Symptomatic neurosyphilis is caused by the bacterium Treponema pallidum. It develops when the infection progresses untreated through earlier stages, allowing the bacteria to invade and damage nervous system tissues. The condition may arise years after initial exposure if syphilis is not adequately treated during primary, secondary, or latent phases.

Risk Factors

• Untreated or inadequately treated syphilis
• Prolonged latency period without medical intervention
• Immune system compromise (e.g., HIV infection)
• High-risk sexual behaviors or exposure to infected individuals

Symptoms

• Neurological deficits: cognitive impairment, memory loss, or personality changes
• Motor dysfunction: weakness, ataxia, or gait abnormalities
• Sensory disturbances: numbness, tingling, or pain in extremities
• Headache, dizziness, or visual disturbances
• Seizures or altered mental status in severe cases

Diagnosis

Diagnosis involves serologic testing for syphilis antibodies (e.g., RPR, VDRL) to confirm infection. Cerebrospinal fluid (CSF) analysis may be performed to detect abnormalities such as elevated protein, white blood cell count, or specific antibody levels. Neuroimaging (e.g., MRI) or specialized neurological assessments may be used to evaluate nervous system involvement.

Treatment Options

• Intravenous penicillin G is the primary treatment for neurosyphilis, administered over an extended period to ensure adequate penetration into the central nervous system.
• Adjunctive therapies may include corticosteroids for inflammation or anticonvulsants for seizure management, depending on symptoms.
• Close monitoring is required to assess treatment response and manage potential side effects.

Prognosis and Follow-Up

Prognosis depends on the extent of neurological damage and timely treatment. Early intervention can improve outcomes, but some deficits may be irreversible. Follow-up includes regular serologic testing and neurological evaluations to monitor for recurrence or complications. Long-term care may be necessary for persistent symptoms.

Complications

• Permanent neurological damage, such as cognitive decline or motor impairment
• Increased risk of stroke or other cerebrovascular events
• Vision or hearing loss due to cranial nerve involvement
• Seizure disorders or chronic pain syndromes

Lifestyle & Prevention

• Safe sexual practices, including consistent condom use, to reduce syphilis transmission risk.
• Routine screening for syphilis, especially in high-risk populations, to enable early detection and treatment.
• Avoiding substance use that may impair immune function or delay seeking care.
• Prompt treatment of primary or secondary syphilis to prevent progression to neurosyphilis.

When to Seek Professional Help

Seek immediate medical attention if experiencing new or worsening neurological symptoms, such as severe headache, confusion, weakness, or visual changes. Early evaluation is critical to prevent irreversible damage. Regular follow-up is recommended for individuals with a history of syphilis to monitor for late-stage complications.

Tips for Medical Coders

Document the presence of neurological symptoms and confirmatory testing (e.g., CSF analysis, neuroimaging) to support the diagnosis of symptomatic neurosyphilis. Ensure clinical correlation with serologic results and specify the affected neurological systems (e.g., central, peripheral) when available. Code A52.1 is appropriate for symptomatic neurosyphilis with documented neurological involvement.